Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer

CONCLUSION: In this study, we found that ACT had better OS than non-ACT in patients with stage IB NSCLC. The nomogram provided an individual prediction of OS for patients after surgical resection. Patients with tumor size >20 mm and ≤40 mm may be potential candidates for ACT.PMID:34335761 | PMC:PMC8313364 | DOI:10.1155/2021/8052752
Source: Journal of Oncology - Category: Cancer & Oncology Authors: Source Type: research